GIA
VERA icon

GHP Investment Advisors’s Vera Therapeutics VERA Stock Holding History

GHP Investment Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43 Hold
1
– – ﹤0.01% 1356
2026
Q1 		$41 Buy
+1
New +$43 ﹤0.01% 1390

Other funds holding VERA

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

GHP Investment Advisors's VERA Position: Q2 2026 in Review

GHP Investment Advisors held its Vera Therapeutics (VERA) position steady in Q2 2026 at 1 share worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

GHP Investment Advisors first reported a position in VERA in Q1 2026 and has held it in 2 quarters since. 28 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • GHP Investment Advisors held 1 share of Vera Therapeutics worth $43 as of Q2 2026.
  • GHP Investment Advisors left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1356 holding.
  • GHP Investment Advisors first reported a position in Vera Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 28 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.